Efficacy Study of ChAd63-MVA ME-TRAP Prime-boost Vaccination Against Plasmodium Falciparum Infection

Trial Profile

Efficacy Study of ChAd63-MVA ME-TRAP Prime-boost Vaccination Against Plasmodium Falciparum Infection

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; Rabies vaccine
  • Indications Malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jan 2017 Status changed from discontinued to completed.
    • 13 Mar 2013 Status changed from active, no longer recruiting to discontinued, as reported by Pan-African Clinical Trials Registry.
    • 13 Mar 2013 New source identified and integrated: Pan-African Clinical Trials Registry record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top